Keyword: carcinoma


FDA Accepts Merck-Pfizer Biologics Application

01.03.2017 - In the course of only a week, the US Food and Drug Administration FDA) has accepted the second Biologics License Application (BLA) for priority review. In the latest case, the...


Genzyme to Acquire AstraZeneca Rare Disease Therapy

29.07.2015 - French pharmaceutical producer Sanofi and its subsidiary Genzyme have agreed to acquire the Caprelsa (vandetanib) rare disease therapy of British-Swedish drugmaker AstraZeneca...